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Abstract
Background and Aim: The study aims to clarify the endoscopic features and clinicopath-
ological differences in superficial Barret’s esophageal adenocarcinoma (s-BEA) derived
from short-segment Barrett’s esophagus (SSBE) and long-segment Barrett’s esophagus
(LSBE).
Methods:We reviewed data of 130 patients (141 lesions) with pathologically confirmed s-
BEA (SSBE: 95 patients and 95 lesions; LSBE: 35 patients and 46 lesions). We analyzed
endoscopic and clinicopathological features of s-BEA in patients with SSBE and LSBE.
Results: The distribution of lesions according to macroscopic findings were as follows
(s-BEA in SSBE vs LSBE): flat type (0-IIb), 3.2% (3/95) vs 32.6% (15/46) (P < 0.001);
accompanied type 0-IIb, 2.1% (2/95) vs 21.7% (10/46) (P < 0.001); and complex type
(0-I + IIb, 0-IIa + IIc, etc.), 30.5% (29/95) vs 50.0% (23/46) (P = 0.025). Complex-type
s-BEAs had high incidences of T1b invasions and poorly differentiated components
(simple type: 22.5% [20/89] and 18.0% [16/89]; complex type: 59.6% [31/52] and
44.2% [23/52], P < 0.001 and P = 0.002, respectively). In SSBE, 72.6% (69/95) of lesions
were located at the right anterior wall (P = 0.01). All flat-type or depressed-type lesions
derived from SSBE were identified as reddish areas, whereas only 65.2% (15/23) from
LSBE were identified as reddish areas (P < 0.001).
Conclusions: In LSBE, flat-type, accompanied-type 0-IIb, and complex-type lesions were
significantly more prevalent. Furthermore, complex-type s-BEAs tended to have T1b inva-
sions and poorly differentiated components. S-BEAs in LSBE should be more carefully
evaluated on endoscopic appearance including flat-type and complex-type lesions than in
SSBE.
Introduction
Barrett’s esophagus (BE) is a precursor for esophageal adenocarci-
noma, which is rapidly increasing in prevalence and has a highly
fatal.1,2 The incidence of esophageal adenocarcinoma has in-
creased over the past decades in many Western countries.3–5 Re-
cently, several reports indicated that the incidence of BE and
Barrett’s esophageal adenocarcinoma (BEA) are rising in Asia be-
cause of the decreasing prevalence of Helicobacter pylori infec-
tion and the westernization of eating habits.6,7
The prevalence of BEA differs according to geographic region.
In addition, a systematic review and meta-analysis suggested that
long-segment Barrett’s esophagus (LSBE) is common in Europe
and the United States,8 whereas in Asia, including Japan, short-
segment Barrett’s esophagus (SSBE) is more common.9,10 The an-
nual rate of progression to BEA significantly differed between
SSBE (0.03–0.07% per year) and LSBE (0.22–0.31% per
year).11–13 Furthermore, because the prevalence of BE differs ac-
cording to region, diagnosis and therapeutic strategies in Asia
are different from Europe and the United States.14
In past, there were several reports comparing BEA derived from
SSBE and LSBE.12,15,16 However, there have been no reports that
have compared the endoscopic features of superficial Barrett’s
esophageal adenocarcinoma (s-BEA) between SSBE and LSBE.
Here, we conducted an analysis to differentiate both the endo-
scopic features and clinicopathological differences of s-BEA be-
tween SSBE and LSBE.
Methods
Study design. This was a retrospective study in which we
identified the endoscopic features (macroscopic type, localization,
and color) according to s-BEA derived from SSBE and LSBE. Ad-
ditionally, we investigated the relationship between macroscopic
type and pathological findings.
Subjects. Between April 2005 and December 2017, we studied
a total of 130 patients (141 lesions) who were pathologically
doi:10.1111/jgh.14827
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confirmed as s-BEA in the Cancer Institute Hospital. The patients
were divided into a SSBE group (95 patients and 95 lesions) and a
LSBE group (35 patients and 46 lesions), and the endoscopic fea-
tures (macroscopic type and localization) were compared between
the two groups. In addition, the color change of flat-type or
depressed-type lesions was compared in terms of white-light imag-
ing (WLI) or narrow-band imaging (NBI) findings, between the
two groups (SSBE group [35 lesions] and LSBE group [23 le-
sions]). These patients underwent endoscopic mucosal resection,
endoscopic submucosal dissection (ESD), or surgical operation
at our institution. We reviewed all medical records retrospectively.
We received written informed consent from all study subjects, and
the Ethics Committee of the Cancer Institute Hospital approved
the study protocol (Approval number: 2016-1073).
Definition of Barrett’s esophagus. The esophagogastric
junction (EGJ) was defined as the lower margin of the palisading
small vessels or the upper end of the gastric folds.17 Endoscopic
diagnosis of the presence of Barrett’s epithelium was determined
upon the observation of columnar epithelium on the proximal side
of the EGJ.17 The length of the columnar-lined esophagus was de-
termined using the Prague C and M criteria.18 According to
Sharma et al., BE was classified as LSBE when the maximum
length of the Barrett’s epithelium was ≥ 3 cm and as SSBE when
the length was < 3 cm.19–22 In the United States and most Euro-
pean countries, the diagnosis of BE requires histologically con-
firmed intestinal metaplasia. However, in the UK and Asian
countries, including Japan, histological examination is not re-
quired according to official guidelines.17 Therefore, in Japan, BE
is commonly diagnosed endoscopically without histological exam-
ination. In this study, we adapted the Prague C and M extents as
the inclusion criteria.
Histology of superficial Barrett’s esophageal ade-
nocarcinoma. BEA was defined as adenocarcinoma that was
endoscopically confirmed in the Barrett’s epithelium, or adenocar-
cinoma observed upon pathological examination of the resected
specimen showing squamous islands, esophageal glands, or dou-
ble layers of muscularis mucosa within the lesion or on the anal
side.17 The depth of tumor invasion was categorized into T1a if
the tumor limited to the lamina propria mucosa or invaded into,
but not through, the deep muscularis mucosa (DMM), or into
T1b if there was the submucosa (SM) invasion. Histological type
was classified into a well-moderately differentiated type, a poorly
differentiated type, or mixed of both types.17 According to the
World Health Organization classification, we defined that poorly
cohesive carcinomas are composed of neoplastic cells that are iso-
lated or arranged in small aggregates. All lesions were diagnosed
by expert two pathologists (H. K. and N. Y.).
Endoscopic diagnosis. We performed high-resolution WLI
endoscopy (GIF-H260 or GIF-H290Z; Olympus, Tokyo, Japan).
In addition, NBI without magnified endoscopy and
chromoendoscopy using indigo carmine were performed. The
macroscopic classification was determined in accordance with
the Japanese Classification of Esophageal Cancer.17 The macro-
scopic type was retrospectively evaluated by three endoscopists
who were certified by the Japan Gastroenterological Endoscopy
Society. The final macroscopic type was determined based on
the consensus of three endoscopists according to the Japanese
Classification of Esophageal Cancer (A. Y., T. S., and J. F.).
We placed each primary macroscopic type into one of two
groups (elevated type and flat or depressed type) based on the clas-
sification of the primary macroscopic type, for example, elevated
types included type 0-I + IIc or 0-IIa + IIc + IIb, whereas flat or
depressed types included type 0-IIb or 0-IIc + IIa. The typical
cases of flat or depressed types are shown in Figure 1. On WLI en-
doscopy, there were reddish flat-type or depressed-type lesions,
and when NBI were utilized, we observed brownish areas.
Furthermore, we classified macroscopic type into simple macro-
scopic type or complex macroscopic type. For example, simple
macroscopic types included type 0-I (0-Is and 0-Ip), 0-IIa, 0-IIb,
and 0-IIc, whereas complex macroscopic types included type 0-
I + IIa or 0-IIa + IIc + IIb (Fig. 2). We classified lesions that in-
cluded 0-IIb components among the complex macroscopic type
as the accompanied type 0-IIb. For example, the accompanied type
0-IIb included type 0-I + IIb or 0-IIa + IIc + IIb. The diagnosis of
flat-type lesions included the accompanied type 0-IIb, which was
evaluated by referencing the histological mapping of resected
specimens, in addition to the endoscopic findings.
Furthermore, the elevated type is easily to find due to its shape,
so we evaluated the color change on flat and depressed types.
Statistical analysis. Fisher’s exact probability test was per-
formed to compare the two groups. The mean values and standard
deviations for age and body mass index, and the median and range
for tumor diameter were analyzed using t-tests and F-tests. When
equal variances were not assumed, Mann–Whitney U-tests were
performed. When the odds ratio (OR) and 95% confidence interval
(CI) of the tumor diameter were calculated, a cut-off value was set
with regard to the median tumor diameter. A P-value < 0.05 was
considered a statistically significant difference. SPSS version 22.0
(SPSS Inc., Chicago, IL, USA) was used for all statistical analyses.
Figure 1 Typical cases of flat or depressed type. On white-light imag-
ing (WLI) endoscopy, there were reddish flat-type or depressed-type le-
sions (yellow arrow). When narrow-band imaging (NBI) were utilized, we
observed brownish areas (red arrow). [Color figure can be viewed at
wileyonlinelibrary.com]
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Results
Baseline characteristics. A total of 130 patients (141 le-
sions) were enrolled in this study. Baseline characteristics of
the study patients are shown in Table 1. There was a higher
prevalence of BEA in males. Multiple lesions presented in five
patients, who were LSBE cases (P = 0.001). The median tumor
diameter was significantly larger in LSBE cases (OR, 2.53; 95%
CI, 1.13–5.64; P = 0.001). The ratio of lesions involving more
than one half of the lumen was significantly larger in cases of
LSBE (OR, 11.3; 95% CI, 2.33–54.8; P < 0.001). The percent-
age of type 0-IIb lesions in the study population was only 3.2%
(3/95) for SSBE, whereas it was 32.6% (15/46) for LSBE (OR,
14.8; 95% CI, 4.02–54.7; P < 0.001). Surgery was the most
common treatment for LSBE (OR, 3.75; 95% CI, 1.68–8.40;
P = 0.001). There was no significant difference in the ratio of
T1b invasion and poorly differentiated components between the
SSBE and LSBE groups.
Figure 2 Examples of different lesion types: sim-
ple macroscopic types include 0-I (0-Is, 0-Ip), 0-IIa,
0-IIb, and 0-IIc; complex macroscopic types include
0-IIa + IIc or 0-IIa + IIc + IIb. We showed the ac-
companied type 0-IIb (orange arrow) and the dia-
grams of different lesion types. [Color figure can
be viewed at wileyonlinelibrary.com]
Table 1 Baseline characteristics
SSBE LSBE P-value
Patient characteristics n = 95 n = 35
Age, years, mean ± SD† 63.9 ± 11.7 62.1 ± 9.7 0.43
Sex, male 82 (86.3) 33 (94.3) 0.35
BMI, kg/m2, mean ± SD† 22.8 ± 3.2 23.0 ± 3.4 0.77
Multiple lesions 0 (0) 5 (14.3) 0.001
Lesion characteristics n = 95 n = 46
Tumor diameter (mm)‡ 15 (10–20) [3–38] 20 (11–30) [1–82] 0.001
More than one half of the lumen 2 (2.1) 9 (19.6) < 0.001
Primary macroscopic type
0-I (0-Is and 0-Ip) 15 (15.8) 7 (15.2) 1.00
0-IIa 45 (47.4) 16 (34.8) 0.21
0-IIb 3 (3.2) 15 (32.6) < 0.001
0-IIc 32 (33.7) 8 (17.4) 0.05
Color
Reddish 91 (95.8) 38 (82.6) 0.02
Treatment
EMR/ESD 2/78 (84.2) 5/22 (58.7) 0.001
Surgery 15 (15.8) 19 (41.3)
Depth of tumor invasion
T1a 59 (62.1) 31 (67.4) 0.58
T1b 36 (37.9) 15 (32.6)
Histological type
Well-moderately differentiated type 69 (72.6) 33 (71.7) 1.00
Mixed type (poorly differentiated component) 26 (27.4) 13 (28.3)
Poorly differentiated type 0 (0) 0 (0)
Data are presented as numbers (%).
†Age and BMI are expressed as mean ± SD (standard deviation).
‡Tumor diameter is expressed as median (interquartile range) [range].
BMI, body mass index; EMR, endoscopic mucosal resection; ESD, endoscopic submucosal dissection; LSBE, long-segment Barrett’s esophagus; SD,
standard deviation; SSBE, short-segment Barrett’s esophagus.
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Macroscopic type. The distribution of all macroscopic types
and T1b invasion rates are shown in Table 2. When we placed
each primary macroscopic type into one of two groups (elevated
type and flat or depressed type), we found that elevated types
accounted for 63.2% (60/95) of SSBE lesions, whereas among
LSBE patients, 50.0% (23/46) of the lesions were flat or depressed
type. The most common macroscopic type of T1b invasion was
type 0-IIa + IIc.
The prevalence of simple and complex macroscopic types is
shown in Table 3. In the SSBE group, simple macroscopic types
accounted for 69.5% (66/95), whereas the complex macroscopic
type accounted for 50.0% (23/46) in the LSBE group (OR, 2.28;
95% CI, 1.10–4.67; P = 0.025). The complex macroscopic type
was more prevalent in the LSBE group than in the SSBE group
(e.g. type 0-IIa + IIb or 0-IIa + IIc + IIb). Among the complex
macroscopic-type lesions with accompanied type 0-IIb, 2.1% (2/
95) and 21.7% (10/46) were SSBE and LSBE, respectively (OR,
12.9; 95% CI, 2.70–61.8; P < 0.001).
Relationship between macroscopic type and path-
ological findings. The relationship between macroscopic
type and the pathological findings are shown in Table 4. T1b inva-
sion rates were 22.5% (20/89) and 59.6% (31/52) in the simple
macroscopic and complex macroscopic types, respectively. More-
over, there was a significant difference, in terms of T1b invasion,
between the complex macroscopic types and simple macroscopic
types (OR, 5.09; 95% CI, 2.42–10.7; P< 0.001). As for the poorly
differentiated component rates, they followed a similar trend as the
T1b invasion rates, with a significant difference between the sim-
ple and complex macroscopic lesion types (simple type: 18.0%
[16/89]; complex type: 44.2% [23/52]; OR, 3.62; 95% CI, 1.68–
7.81; P = 0.002). Most s-BEAs with poorly differentiated compo-
nents showed SM invasion, with some showing DMM invasion
(DMM: 17.9% [7/39]; SM: 79.5% [31/39]). In addition, poorly
differentiated adenocarcinomas were frequently seen in part such
as type 0-IIa or 0-IIc included accompanied type 0-IIc.
Localization. The details of localization in the study patients
are shown in Table S1. We found that the lesions located at the
right anterior wall (0–3 o’clock position) in the lower esophagus
accounted for 72.6% (69/95) of SSBE lesions, whereas, 47.8%
(22/46) of LSBE lesions were located in regions other than the
right anterior wall (OR, 0.38; 95% CI, 0.18–0.78; P = 0.01). We
evaluated whether the lesions were adjoined at the upper end of
the BE. In SSBE lesions, 96.8% (92/95) of lesions were located
at the upper end of the BE, indicating that most lesions were lo-
cated at the lower end of the squamous epithelium. In contrast,
the lesions in the LSBE group located at the upper end of BE only
accounted for 65.2% (30/46) of lesions (OR, 0.06; 95% CI, 0.02–
0.22; P < 0.001).
Color change of flat-type or depressed-type super-
ficial Barret’s esophageal adenocarcinoma. The
color changes in flat-type or depressed-type lesions are shown in
Table S2. In cases of SSBE, all lesions were identified by both a
reddish area and a brownish area when NBI was employed. For
LSBE lesions, only 65.2% (15/23) of lesions were identified by
a reddish area (OR, 1.53; 95% CI, 1.14–2.07; P < 0.001), while
73.9% (17/23) were observed as a brownish area (OR, 1.35;
95% CI, 1.06–1.73; P = 0.002). A representative case of LSBE
is shown in Figure 3. On WLI endoscopy, we could not recognize
the lesions clearly. When we used NBI, on the anterior side, the le-
sions were detected as brownish areas. For this case, NBI was
found to be particularly useful.
Discussion
This study is the first report on the endoscopic differences, such as
macroscopic type, of s-BEA between SSBE and LSBE. Matsui
et al.23 reported conventional white light endoscopic features of
s-BEA in SSBE (30 patients and 30 lesions), although there were









Elevated type n = 60 n = 24 n = 23 n = 11
0-I† 11 (11.6) 2 (5.6) 2 (4.3) 2 (13.3)
0-I + IIa — — 1 (2.2) —
0-I + IIa + IIb — — 1 (2.2) 1 (6.7)
0-I + IIb 2 (2.1) 1 (2.8) 1 (2.2) 1 (6.7)
0-I + IIc 2 (2.1) 2 (5.6) 1 (2.2) 1 (6.7)
0-I + IIc + IIb — — 1 (2.2) 1 (6.7)
0-IIa† 24 (25.3) 6 (16.7) 1 (2.2) —
0-IIa + I 1 (1.1) — — —
0 -IIa + IIb — — 3 (6.5) —
0-IIa + IIc‡ 20 (21.1) 13 (36.1) 10 (21.7) 4 (26.7)
0-IIa + IIc + IIb — — 2 (4.3) 1 (6.7)
Flat or depressed
type
n = 35 n = 12 n = 23 n = 4
0-IIb† 3 (3.2) — 15 (32.6) 2 (13.3)
0-IIc† 28 (29.5) 8 (22.2) 5 (10.9) —
0-IIc + I 1 (1.1) 1 (2.8) — —
0-IIc + IIa 3 (3.2) 3 (8.3) 1 (2.2) 1 (6.7)
0-IIc + IIb — — 1 (2.2) 1 (6.7)
0-IIc + III + IIb — — 1 (2.2) —
Complex types are presented as primary + accompanied macroscopic
type. Data are presented as numbers (%).
†Simple type. Other macroscopic types are complex type.
‡The most common macroscopic type of T1b invasion is shown in bold.
LSBE, long-segment Barrett’s esophagus; SSBE, short-segment
Barrett’s esophagus.
Table 3 Distribution of simple and complex macroscopic types
SSBE (n = 95) LSBE (n = 46) P-value
Simple type† 66 (69.5) 23 (50.0) 0.025
Complex type‡ 29 (30.5) 23 (50.0)
Accompanied type 0-IIb 2 (2.1) 10 (21.7) < 0.001
Data are presented as numbers (%).
†Simple type: 0-I, 0-IIa, 0-IIb, and 0-IIc.
‡Complex type: 0-I + IIa, 0-IIa + IIc + IIb, and so on.
LSBE, long-segment Barrett’s esophagus; SSBE, short-segment
Barrett’s esophagus.
Endoscopic features of s-BEA A Yamasaki et al.
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few comparisons with LSBE. Moreover, the prevalence of multi-
ple neoplasia was significantly correlated with tumor size and
length of BE.15 However, to our knowledge, there have been no
reports that have compared the endoscopic features of s-BEA be-
tween SSBE and LSBE.
The current study described differences in macroscopic types,
between SSBE and LSBE groups; flat-type lesions, including the
accompanied type 0-IIb, were significantly more prevalent in
LSBE cases, making it difficult to detect s-BEA in LSBE, as com-
pared to SSBE. Therefore, it is important to detect flat-type lesions
associated BEA in the LSBE group. Type 0-IIb and the accompa-
nied type 0-IIb were very important macroscopic types, because
they related to detection and diagnosis for a range of lesions.
As previously noted, therapeutic strategies are different in Asia
than in Europe and the United States. In Japan, complete tumor
resection by ESD is preferred, whereas in Europe and the United
States, endoscopic mucosal resection for visible lesions combined
with radio-frequency ablation for residual metaplasia epithelium is
recommended for BEA.24,25 Furthermore, in Europe and the
United States, random biopsy based on the Seattle protocol re-
mains the gold standard to identify dysplasia or adenocarcinoma
before treatment.26 Conversely, Japanese endoscopists usually
conduct an endoscopically targeted biopsy for a lesion suspected
of adenocarcinoma. As LSBE is common in Europe and the
United States, high-grade dysplasia and flat-type lesions are com-
monly detected. Therefore, it seems reasonable that random biopsy
and radio-frequency ablation are conducted in Europe and the
United States. However, as we are careful about flat-type lesions
in diagnosing patients with LSBE, we believe that ESD might be
an appropriate standard treatment. Therefore, we believe that
Table 4 Relationship between macroscopic type and pathological findings
Data are presented as numbers (%).
LSBE, long-segment Barrett’s esophagus; SSBE, short-segment Barrett’s esophagus.
Figure 3 A representative case of LSBE. On white-light imaging (WLI)
endoscopy, we could not recognize the lesions clearly. When narrow-
band imaging (NBI) was utilized, we observed brownish areas on the an-
terior side (yellow arrow). In this case, NBI was very useful. [Color figure
can be viewed at wileyonlinelibrary.com]
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ESD is a potential effective therapeutic option for esophageal neo-
plasms in patients with LSBE, as well as SSBE.27 A total of 86 pa-
tients who underwent ESD in the previous study were included in
this study (SSBE: 68 of 78 cases; LSBE: 18 of 22 cases).27 Based
on our data, multiple lesions and the ratio of lesions involving
more than one half of the lumen were significantly higher in LSBE
cases (Table 1). Therefore, when diagnosing or treating s-BEA in
LSBE, caution should be paid to lesions, including the accompa-
nied type 0-IIb or multiple lesions.
The incidence of complex macroscopic-type lesions was higher
in LSBE than SSBE (Table 3). SSBE lesions are easier to detect
than LSBE, and the rate of simple macroscopic types was higher.
Therefore, we considered endoscopic treatments to be more com-
mon in SSBE cases. There was no significant difference in the ra-
tio of T1b invasion and poorly differentiated components between
the SSBE and LSBE groups (Tables 1 and 4). However, in the en-
tire s-BEA, complex macroscopic-type lesions had a high inci-
dence of T1b invasion and poorly differentiated components
(Table 4). The most common macroscopic type of T1b invasion
was type 0-IIa + IIc (Table 2). Therefore, special attention should
be paid to T1b invasion and poorly differentiated components
when diagnosing s-BEA of complex macroscopic types.
The localization of the lesions is an important factor in s-BEA
detection. s-BEA is frequently found in the right or anterior wall
of the EGJ.28–30 As previously reported, our study revealed that
s-BEA in SSBE were typically located at the right anterior wall
of the EGJ, whereas s-BEAs in LSBE were located at both the
posterior wall to the left wall, as well as the right anterior wall
(Table S1). We reported that the location of s-BEA mostly corre-
sponds to the direction of gastroesophageal reflux,31 by using a
pH catheter with eight sensors developed at the Shimane Medical
University and Star Medical (8-channel pH catheter SA800,
Tokyo, Japan).32 In many cases, acid reflux was located at the
right anterior wall, which corresponded with the location of
cancer. If s-BEAs were detected in a location other than the right
anterior wall side, it can be speculated that there might be acid
reflux in the direction of the lesion’s position. Therefore, by
knowing the location of acid reflux using pH monitoring, we
may easily detect s-BEA in LSBE at an early stage. In particular,
given that the localization of LSBE lesions is not necessarily at
the right anterior wall, knowing the direction of acid reflux would
aid in detecting s-BEA.
For flat-type or depressed-type lesions, color change is also an
important factor in s-BEA detection. In SSBE cases, all lesions
were identified as both a reddish and brownish area. Although in
LSBE cases, we could identify only 65.2% of lesions by reddish
areas on WLI endoscopy, and we could observe 73.9% of these le-
sions as brownish areas using NBI (Table S2). Our findings sug-
gest that in cases of LSBE, some lesions could not be recognized
as reddish areas. It would therefore be useful to observe such
BEA lesions with weakly magnifying endoscopy using NBI. How-
ever, even if NBI could be employed, there are still a significant
number of cases in which we cannot detect s-BEA in LSBE le-
sions. Flat-type lesions included the accompanied type 0-IIb could
not be detected, which were evaluated by referencing the histolog-
ical mapping of resected specimens.
Among the BE patients followed up at our institute during the
study period, an estimated 1000 patients had SSBE and 36 had
LSBE. During the follow-up period, progression to BEA was seen
in the following cases: SSBE, one to two cases per year, and
LSBE, one case.
In this study, if the palisading small vessels were unclear, the
upper end of the gastric folds were defined as the EGJ.17 The
position of the upper end of the gastric folds may not be well
visualized in the context of atrophic gastritis, which is frequently
encountered in Japan.33,34 There were only a few cases with no de-
finitive histological criteria, and these cases were found endoscop-
ically in the palisading small vessels. According to the World
Health Organization classification, the diagnosis of BE is restricted
to columnar epithelium with goblet cells in North America and
parts of Europe.35,36 However, some authorities accept columnar
epithelium without goblet cells as a part of the definition.37–40
This study was subject to some limitations. First, we used a
retrospective study design. Second, the study was performed at a
single center. Prospective studies at multiple centers would be
warranted to verify our results.
In conclusion, in SSBE, s-BEAs were often recognized as an el-
evated reddish appearance located at the right anterior wall of the
EGJ. In LSBE, flat-type lesions, including the accompanied type
0-IIb, and multiple lesions, the ratio of lesions involving more than
one half of the lumen, and complex macroscopic types were sig-
nificantly more prevalent. When we diagnose and treat s-BEA, it
is necessary to consider the differences between s-BEA derived
from SSBE and that from LSBE, such as macroscopic types.
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